Join a Legacy of Innovation 110 Years and Counting!
Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. Under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.
Summary
The purpose of this role is to drive real-world evidence (RWE) generation under the remit of the Global Oncology HEOR/RWE team in the Global Oncology Value, Access, and Pricing (GOVAP) department. The Associate Director, Global Oncology RWE Generation will report directly to the Global Oncology RWE Lead and will work closely with the Global Oncology RWE team and Global Oncology HEOR/RWE asset leads on tactical planning and execution of evidence generation studies across the oncology portfolio, contributing to successful market access for Daiichi Sankyo assets. This role will also contribute to the development of internal capabilities and processes related to real-world data (RWD) acquisition and governance, operational excellence in delivery of evidence generation studies, information dissemination, as well as building and retaining institutional memory within Daiichi Sankyo. The Associate Director, Global Oncology RWE Generation will work in close collaboration with cross-functional teams, both within and outside of the Oncology Business Unit (OBU), and in close alignment with global and regional functions. Key cross-functional collaborating partners for this role include Regional HEOR/RWE and Market Access teams, Global Oncology Medical Affairs (GOMA) and its relevant functions, R&D, Digital Intelligence (biostatistics), and other teams involved in the planning, conduct, and dissemination of RWE generation projects.
Responsibilities
– Drive strategic evidence generation planning and execution of RWE studies using secondary data sources, including tactical planning, study operational start-up (RFP/RFI, vendor selection), feasibility assessments, project management, preparation and review of study documents, as well as internal and external dissemination of project results.
– Effectively manage RWE project implementations, including managing outsourcing activities with external consultancies and contractors, ensuring delivery according to key milestones, budget and to agreed and expected quality.
– Drive and facilitate evaluations and cataloguing of candidate RWD sources for project planning and data acquisition, and maintain current knowledge on the evolving use of RWE for market access and payer negotiations.
– Identify priority areas and facilitate dissemination (coordinate scheduling, oversee and track meetings, developing materials) of RWE generation information for internal stakeholders across relevant committees (GAT, GPT, etc.), regional/local, asset, disease area, and Alliance teams.
– Work collaboratively and provide HEOR/RWE and payer perspectives in cross-functional RWE projects, proactively identifying opportunities for innovative methods of filling knowledge gaps.
– Collaborate closely and keep updated with members from other departments such as Regional HEOR/RWE and Market Access, Global Medical Affairs, RD, and Digital Intelligence to maintain communication on key global and regional RWE activities.
– Develop and maintain an institutional memory on use of RWE for reimbursement and HTA submission in key global markets; tracking evolving policies and new initiatives and its implications for operational delivery of DS RWE projects.
– Keep informed of new and innovative RWD products and RWE generation capabilities within the industry, arranging for vendor demos and introductory meetings where appropriate.
Qualifications: Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.
Education Qualifications (from an accredited college or university)
– Bachelor’s Degree in relevant discipline (eg. health economics, public health, epidemiology, health informatics) required
– Master’s Degree in relevant discipline (eg. health economics, public health, epidemiology, health informatics) required
– PhD in relevant discipline (eg. health economics, public health, epidemiology, health informatics) preferred
Experience Qualifications
– 7 or More Years Years Overall related experience in healthcare industry (pharma, consulting, contract research organization) and/or commensurate education and experience required.
– 5 or More Years experience in HEOR/RWE roles conducting evidence generation projects in the healthcare industry (pharma, consulting, contract research organization) required.
– Demonstrated understanding and knowledge of key drug development processes, plans, studies, and strategies including clinical, regulatory, scientific, operational, and commercial aspects of drug development. Uses knowledge to the organization’s advantage; generates new ideas and enables the organization to improve business performance required.
– Knowledge and prior experience working in Oncology therapeutic areas required.
– Strong project management experience with a proven track record of successful execution of RWE studies with internal cross-functional and external stakeholders in major international markets (US, Europe, Asia) required.
– Understanding of requirements and guidelines on evidence generation needs for reimbursement and HTA submissions in key international markets preferred.
– Demonstrated expertise and experience working with methods for evidence generation using secondary data sources, knowledge of common issues and challenges of implementation, and track-record of successful publications preferred.
– Expertise in various RWD sources (EMR/EHR, claims, disease registries, etc.) and clinical data standards, as well as understanding of RWD landscape across various geographies and be familiar with market-specific data quality and coverage considerations preferred.
Travel
Ability to travel up to 30%
Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.
br{display:none;}.css-58vpdc ul > li{margin-left:0;}.css-58vpdc li{padding:0;}]]> Identify Privileged Accounts/Access across AD, Cloud, and other platforms. Integrate Privileges Accounts with the PAM...
Apply For This Jobbr{display:none;}.css-58vpdc ul > li{margin-left:0;}.css-58vpdc li{padding:0;}]]> Summary Posted: Mar 4, 2022 Weekly Hours: 20 Role Number:200352962 Do you love hands-on problem...
Apply For This JobAbout the Department Our Boston Research & Development hub, anchored in the greater Boston area, brings together the best minds...
Apply For This JobJob Description In April 2020, our Company announced plans to consolidate our New Jersey campuses into a single New Jersey...
Apply For This Jobbr{display:none;}.css-58vpdc ul > li{margin-left:0;}.css-58vpdc li{padding:0;}]]> Job Description: Telos is seeking IT Planners to join our team at a multitude of...
Apply For This JobJob Description Join a Legacy of Innovation 110 Years and Counting! Daiichi Sankyo Group is dedicated to the creation and...
Apply For This Job